Sign in to fuzzto save your conversations, follow your research and come back anytime.
Vijaya Diagnostic Centre
SectorHealthcare
Vijaya Diagnostic Centre Limited is an Indian company founded in 1981 and incorporated in 2002. It is the largest integrated diagnostic chain in South India, providing a comprehensive range of diagnostic services including pathological investigations, radiology, nuclear medicine, and related healthcare services. The company operates over 121 diagnostic centers across 20 cities in India, offering laboratory services, radiology and imaging, cardiology, neurology, and gastroenterology services. In 2021, Vijaya Diagnostic Centre Limited went public with an IPO of Rs 1895.04 crore and its shares were listed on the BSE and NSE.
The Quarter story
The two most recent quarterly results, compared side-by-side.
Vijaya Diagnostic Centre delivers steady revenue and profit growth driven by network expansion and higher test volumes, while rising operational and financing costs require monitoring.
Revenue grew from ₹1,880.5 Cr in Q1 FY26 to ₹2,309.8 Cr in Q1 FY27 — steady top-line expansion
Employee costs rose from ₹316.1 Cr in Q1 FY26 to ₹374.8 Cr in Q1 FY27 — scaling workforce expenses
PAT margin rose from 20.4% in Q1 FY26 to 23.0% in Q1 FY27 — improved bottom-line efficiency
Finance costs increased from ₹74.9 Cr in Q1 FY26 to ₹110.0 Cr in Q1 FY27 — higher borrowing impact
Centre count expanded from 157 in Q1 FY26 to 166 in Q1 FY27 — consistent network growth
FII stake fell from 19.6% in Q1 FY26 to 11.7% in Q1 FY27 — sustained foreign capital reduction
Revenue per test increased from ₹477 in Q1 FY26 to ₹503 in Q1 FY27 — stronger pricing and test mix
Material costs climbed from ₹214.1 Cr in Q1 FY26 to ₹256.0 Cr in Q1 FY27 — volume-driven input consumption
DII stake grew from 24.1% in Q1 FY26 to 31.6% in Q1 FY27 — rising domestic institutional confidence
Radiology mix dipped from 38.5% in Q1 FY26 to 37% in Q1 FY27 — slight segment share compression
